{"name":"Lantern Pharma Inc.","slug":"lantern-pharma-inc","ticker":"","exchange":"","domain":"","description":"Lantern Pharma Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies. The company's pipeline includes two drug candidates, LP-300 and LP-284, which are in Phase 2 and Phase 1 trials, respectively.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":11514123,"netIncome":-17119438,"cash":4422838,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQZnlFRUNkYXlISzV0YndYWWhseVI5WlBwTnpxMnEtZE14elJoVDhMY0R1cmpqb0t5cFV2ZnRteVp5MDRaUkVMQTdkRWdyM2VJUlJNdjdBMkhlYktlMkFRYnlLWkZfaVhlWVFfUjA2LWxyQW8zeEFObGpNajBJWkMtUDNERGxXdEJweG90Mm5ZMHp0UHhjU2lLOUs4MmRGSDdybUtnNFdnT1F3WkFQNC1rSFB0U3RhTkRRNF9aRTNkdk55UDQ?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Lantern Pharma (NASDAQ: LTRN) insider holds 570,000 shares, 5.1% stake - Stock Titan","headline":"Lantern Pharma (NASDAQ: LTRN) insider holds 570,000 shares, 5.1% stake","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQY2Q3aG5famFjeWpPemFlb1VtNjIzTWtkOHQ0OXB0dk50N3BDZmx0Vl9LNWVoMzR5c0VLVXpfdGZWWEY0QkZFMWc5MDVxRTI1eEhnbEJBLWpCWG5TeVFIVDlfVElvS0hUaGhPYm9YN0pxLVBCdlh4ODItNjBKRVhpTTdpRXZhN251ZGhUTWJCMWllTEhVaEZfaE5TT2Z4MEZBSTlLNi0xQkprZlhQUXc0cC1HbEJwT0xKTjhVemduekV0OFJzUkJfX2VwNTJYTTM2c0EzUnNSSXVWVThGVGFyU1k0cTVBVTA?oc=5","date":"2026-04-03","type":"earnings","source":"GuruFocus","summary":"Lantern Pharma Inc (LTRN) Q4 2025 Earnings Call Highlights: Stra - GuruFocus","headline":"Lantern Pharma Inc (LTRN) Q4 2025 Earnings Call Highlights: Stra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQREM3UjZaazNjbEVXQks1eWNNNzFRbVRsRk9SMlZrY1plb3dUcnlsSVJ3WjFZNzlFaERyYUZ1TXN4dkhwbDhUbmlVaVREUk50WVhrUlk4V0NMMTBta2dJR3IzMFd1a2VuZWVfR2NGeE5MbUZrZjI4b1dDVUlXZGIxSlFHeWxVb19mV1VTcmxzODVva1NhMFdISE9XRjVIcTQ4Y2M3czFxYmVlYnUtQU44?oc=5","date":"2026-04-02","type":"pipeline","source":"Yahoo Finance","summary":"Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of withZeta.ai — the World's First Multi-Agentic Co-Scientist for Rare Cancers — 8:","headline":"Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPLVgwaXN0clF6RFBDVDduOGpnbk9wcG9nMGFta1B0VGxRalJ5dFpzeUJVLVBBZFhWRnE4QUNtYUNXcElsTTZKUEx6Y2NHRl9CWTlCcEttS0pfUnNpdWZaeEhpak51Z3hVYzB2cjVyU3o2RVEzWHlXV2JXcHJqREtXUkpCYXM5Wlh6ckdkd1FEeTlQdFVuMVlrelVQZk9ISTloOENEYUdfLURaTm1pWlYweERuWmxQeGplTWFDLQ?oc=5","date":"2026-04-02","type":"pipeline","source":"GuruFocus","summary":"Lantern Pharma (LTRN) to Showcase AI Innovation in Rare Cancer R - GuruFocus","headline":"Lantern Pharma (LTRN) to Showcase AI Innovation in Rare Cancer R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOSXA0c1BPVG5pSHdtejRJRGo4cWhGS2g3c0plVE9XbVR2dGdtR2w3RlNDdXdZTXdfc0JUUi1lT3IwUHNoRHd2b3NPenFtZm55NU12cVJXRVdrQ2JDaldRd2RnZGJOdHZHSnBTZGVtaUxWLUE4WjUzS3NmWlhVWTVTbm1HUGVyY1Q0d2xYMkdlV1hOSGVqNmpfa1haZUFUUnVMVEFDV0pFN2ExdTdRamZzUlV6ZVg4LXhkWGRmZDBaQ0ZMWXYxWEI5NUlEajY5SmZqWHhxd0hWOUNFdkZl?oc=5","date":"2026-03-31","type":"earnings","source":"BioSpace","summary":"Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - BioSpace","headline":"Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNcklRenVEQVlaRHRtVkVhMGtRZU1EME5WTmN0UVUwZ0lEcmJzSVA3ckZFVG02Nkttc0xiS3R4emh0SkNjYy0wTWFac3VaZWFIaDBlbmV2S2VDbnlfNzRtZmlEem84MTB0ZnlyajlKMXN0aEFsMHM4YThNRFY0R2JPQVh0R2MwWGJKQ1RadkNiOXZMTlktX0RNUGR3b213TmNvcUdGVVZ3YUNNMHRWT2NGR3ZnRU84UXFrM0VEWEt4Tjc0Z1p6Y0VUNEV4U0dENi0tbjJGVHBadzctM1cxYmxDZG5OQ1U2aUItRV9CNA?oc=5","date":"2026-03-31","type":"earnings","source":"TradingView","summary":"Lantern Pharma Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView","headline":"Lantern Pharma Inc reports results for the quarter ended September 30 - Earnings Summary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQY3ZSUlItdzVHeGhjZlA0cUxkMldlM1g0WEpZdmxGNmpmcVVteVJpc1B0SzZfRElreV9ucGQ0bGpRZFRDVGppaG52UUwzZUJuSmJkM3FNZTNjYlFYQnVHRi1LQ0M0NzMwc08yak9ycHI3TFVWQmNZdnJHOTl1blRPbTM1UTFnZGZLblBfU21pajdqSlRzMjZJOV9XTVdwSS1GNGVucA?oc=5","date":"2026-03-30","type":"earnings","source":"Seeking Alpha","summary":"Lantern Pharma Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:LTRN) 2026-03-30 - Seeking Alpha","headline":"Lantern Pharma Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:LTRN) 2026-03-30","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNV2hYdDRfNTVGeTJuc0d3a0xiMEdVc0k0OTg2VkJjMHdwd2FzYk51S3VpbHk1TUFCVFRnc1l3RXdtdDhpanNtQ1Bad2xpRC1Ib3JkVjUwdFdtLXo2Q1h3ejZzZkxXMlkxd1E1NFVGWXFPME02M3ZwZVQ3TldvZEU2RXh4TXgyclkwT2NtRUZBUUJUZVJ6SlAwZjVMYmdINktJOVI4Ulg3TlNoaTV3M0REdjEzY0Y3WllZVlJMamwyV0hOVi14WTh5Q1JGVGZzLXlqLVE?oc=5","date":"2026-03-30","type":"earnings","source":"Investing.com","summary":"Earnings call transcript: Lantern Pharma Q4 2025 sees EPS improvement, stock jumps - Investing.com","headline":"Earnings call transcript: Lantern Pharma Q4 2025 sees EPS improvement, stock jumps","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZ1pXaWE2TXllSl8yWVF3bjE5cklhVkNiZk5qWFB3dGtVeWJ6dVRIYnVvaFAwN3BuZERnTUZuWktNaXdqZlpoN081UmZPLXczRWZuRktlT2RTT1dCT2JGanoySTIxVjJXTVdTTV92Mm5MS250bnFDSVUyR2pmUVd0Wm5rSTR1Y2xsM2lsenVLLTBqQzVabklNWHJEd2poNnNCRXVpLTNqd2I?oc=5","date":"2026-03-30","type":"pipeline","source":"Stock Titan","summary":"Lantern Pharma (NASDAQ: LTRN) outlines AI-driven cancer pipeline and going concern risk - Stock Titan","headline":"Lantern Pharma (NASDAQ: LTRN) outlines AI-driven cancer pipeline and going concern risk","sentiment":"neutral"},{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxNUU9QSW5BWURISjlPTmt3dHhUd1NaNFZkcXJ2N093ay1XQWtVbjlVd3A2eF94SFlCNS1CSHF2TWVia3gyLU01amNxVGQtaVYyZUxNYkpTZjZ2eFpsNVhjZ2MzME5jZDlSUkdxRS1oREYzVF9MV2tLZnBIbXNxOC0wN2taM25CQW5KWmI1Qkd2TWhnXzcyNzJmQ18yUFFOVTFCTURSWHlRZHhBWVRNVy1IVXE3blBWWVYwZUxXTjhfSnFLSVlSR3ZxX2RyOUxObUlhM0NZRVJraWV3d0JvYmVrQi10b2pueXJGNDlEVTQ3UWN2MlNBeWdQdEZzXy1yZzl4c0l2OEZBRkRodw?oc=5","date":"2026-03-27","type":"pipeline","source":"Business Wire","summary":"Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Report - Business Wire","headline":"Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Repo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxNVlRMVGtQWFF4cnFhS1BkUzRTMFpRd2g5VnQ3cXVtdEhReUFiYWF5VGFhTElsdmpWZkhmdGhGb0NxWE95RzZfYXZSZ181N2p2dkJVRzJlMWpMa1ZtcjN0ZkNGTmF4bnF5ZnphQnJtM1pkaGdWSG1idk5PZW5NaXUya1E0Q2tyM3RwMVAzQkZHNTBPS2pjeHY5MjQxT2o1akVFTWdUS3Q5eDdrVUlKdXBUaG9WV2hIUHB6b1FEcWVzZlUxRHJ0LTY0VkJtaEFPZUE3NW5sdmZoaEhzNDk2ZXRpeV9TOFBKaFJsREZmMnRMM0NPeFYyUVpkSktxOEx5RXczbTk4eV80ZWs1QQ?oc=5","date":"2026-03-23","type":"earnings","source":"ChartMill","summary":"Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET - ChartMill","headline":"Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOeGVURmJYckg4NF9UenQ3VjFBbk9Hak1jMEktcEk1WW42cF9BRkpnaXFmYVpUN0tldWl6YmpUV0Vpd0FkNmxZX295cHVZaExJc1VzalFwZ0hSYzU3ai1LaF9Yc1NrWlBlSENjTFNwN2ZBQVBCSW9SQmlsX2ZaWDM3M1VjWnhILWhuZDRN?oc=5","date":"2026-02-12","type":"pipeline","source":"Yahoo Finance","summary":"Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition - Yahoo Finance","headline":"Lantern Pharma (LTRN) Advances Oncology AI and Gains Orphan Drug Recognition","sentiment":"neutral"},{"date":"2026-01-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":11514123,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-17119438,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":4422838,"cashHistory":[],"totalAssets":11035811,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}